Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / Class A Common Stock, $0.001 par value per share
-
Shares outstanding
-
58,762,797
-
Total 13F shares
-
9,594,278
-
Share change
-
-2,276,996
-
Total reported value
-
$12,279,759
-
Price per share
-
$1.28
-
Number of holders
-
57
-
Value change
-
-$9,114,134
-
Number of buys
-
36
-
Number of sells
-
37
Institutional Holders of Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX) as of Q2 2024
As of 30 Jun 2024 Immuneering Corp - Class A Common Stock, $0.001 par value per share (IMRX) had 57 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 9,594,278 shares of stock of the company.
Largest 10 holders included CITADEL ADVISORS LLC, VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, PRICE T ROWE ASSOCIATES INC /MD/, GOLDMAN SACHS GROUP INC, Prosight Management, LP, BlackRock Inc., MARSHALL WACE, LLP, RENAISSANCE TECHNOLOGIES LLC, and TWO SIGMA ADVISERS, LP.
This table shows 57 institutional shareholders of the security as of 30 Jun 2024.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.